RocketTickers

Soligenix Announces Positive Top-line Results for its Pivotal Ph

Long
NASDAQ:SNGX   Soligenix, Inc.
SNGX: Soligenix, Inc.
2020-03-19 06:00:00
Soligenix Announces Positive Top-line Results for its Pivotal Phase 3 FLASH Trial Evaluating SGX301 in Treatment of Cutaneous T-Cell Lymphoma
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.